InMed Pharmaceuticals (INM) EBIT Growth (1y) (2022 - 2026)
InMed Pharmaceuticals (INM) EBIT Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 25.63% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.30% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -14.89% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -46.83% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 719.49% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 23.29% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -450.06% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -235.28% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -20.32% |
| 10 | InMed Pharmaceuticals | 6.04 Mn | 796,124.14 | - | -46.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.32% |
| Dec 31, 2025 | 6.72% |
| Sep 30, 2025 | -4.94% |
| Jun 30, 2025 | -21.33% |
| Mar 31, 2025 | -3.45% |
| Dec 31, 2024 | -37.03% |
| Sep 30, 2024 | 35.09% |
| Jun 30, 2024 | -319.30% |
| Mar 31, 2024 | 14.29% |
| Dec 31, 2023 | 25.70% |
| Sep 30, 2023 | 25.26% |
| Jun 30, 2023 | 92.56% |
| Mar 31, 2023 | 39.20% |
| Dec 31, 2022 | 48.66% |
| Sep 30, 2022 | -20.34% |